Can specific genetic variants change the risk of metabolic problems in MASLD?
Yes, specific genetic variants like PNPLA3-I148M and PON1 variants can increase the risk of metabolic problems and liver damage in MASLD.
Read the full answer →Can chiglitazar help reduce liver fat in MASLD patients with high triglycerides?
Yes, a phase II trial found chiglitazar significantly reduced liver fat in MASLD patients with high triglycerides and insulin resistance.
Read the full answer →Are there natural herbal plants that target autophagy for Metabolic-Associated Fatty Liver Disease?
Research suggests natural herbal plants can target autophagy pathways in Metabolic-Associated Fatty Liver Disease, offering a multi-target approach that may be safer than single-drug therapies.
Read the full answer →Does curcumin help reduce weight in Metabolic-Associated Fatty Liver Disease patients?
Curcumin helps reduce weight in Metabolic-Associated Fatty Liver Disease patients but does not significantly change BMI or waist circumference.
Read the full answer →Can bile acid regulation help with MASLD liver fibrosis?
Regulating bile acids can help treat MASLD liver fibrosis because these chemicals directly activate cells that cause scarring and disrupt liver function.
Read the full answer →Are there any validated treatments for metabolic dysfunction-associated fatty liver disease mentioned in recent reviews?
Recent reviews highlight lifestyle changes and emerging drugs like resmetirom, but no universally validated treatment exists yet for MASLD.
Read the full answer →What specific outcomes are currently known about metabolic dysfunction-associated fatty liver disease from recent reviews?
Recent reviews show MASLD is the leading cause of chronic liver disease, drives liver transplant needs, and involves complex links between gut bacteria, circadian rhythms, and mitochondrial function.
Read the full answer →Can machine learning models help doctors diagnose my metabolic dysfunction-associated steatotic liver disease?
Yes, machine learning models can help diagnose MASLD and predict complications like liver cancer, with studies showing high accuracy (up to 91%) for detecting fatty liver on ultrasound and predicting HCC risk.
Read the full answer →